FDA
approval
· 2023-03-27
FDA Approved: NARCAN — Supplemental Application (Emergent Devices Inc.)
Summary
FDA approved a supplemental application for Narcan nasal naloxone from Emergent Devices Inc., approving an addition to the already approved product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NARCAN (NALOXONE HYDROCHLORIDE NASAL)